"The Skinny on Ozempic: A Thursday at 6 Exclusive"

Ozempic, a GLP-1 receptor agonist developed by Novo Nordisk, has been shown to be effective in treating type 2 diabetes and promoting weight loss. The drug works by mimicking the effects of a hormone called GLP-1, which helps regulate blood sugar levels and appetite. Ozempic is administered once a week via injection and has been approved by the FDA for use in adults with type 2 diabetes.